Potential determinants of drug-drug interaction associated dispensing in community pharmacies

Drug Safety

Volumn 28, Issue 5, 2005, Pages 371-378

  Becker, Matthijs L ^a,b,c   Kallewaard, Marjon ^a   Caspers, Peter W J ^a   Schalekamp, Tom ^c   Stricker, Bruno H C ^b,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Drug Safety Unit   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT;

BIBLIOGRAPHIC DATABASE; COMPUTER PROGRAM; DRUG INTERACTION; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LANGUAGE; MEDICAL LITERATURE; MEDLINE; PHARMACIST; PHARMACY; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; WORKLOAD;

COMMUNITY PHARMACY SERVICES; DRUG INTERACTIONS; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 19544394711     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200528050-00001     Document Type: Review

References (26)

1. Schalekamp T. Omgaan met geneesmiddeleninteracties. Geneesmiddelenbulletin 1997; 31 (8): 87-94
2. Bergendal L, Friberg A, Schaffrath A. Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. Pharm World Sci 1995; 17 (5): 152-7
3. Linnarsson R. Drug interactions in primary health care: a retrospective database study and its implications for the design of a computerized decision support system. Scand J Prim Health Care 1993; 11 (3): 181-6
4. Merlo J. Liedholm H, Lindblad U, et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001; 323 (7310): 427-8
5. Buurma H, de Smet PA, van den Hoff OP, et al. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001; 52 (1): 85-91
6. Caleo S, Benrimoj S, Collins D, et al. Clinical evaluation of community pharmacists' interventions. Int J Pharm Pract 1996; (4): 221-7
7. Hawksworth GM, Corlett AJ, Wright DJ, et al. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999; 47 (6): 695-700
8. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care 1992; 30 (10): 926-40
9. Westein MP, Herings RM, Leufkens HG. Determinants of pharmacists' interventions linked to prescription processing. Pharm World Sci 2001; 23 (3): 98-101
10. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999; 21 (6): 245-50
11. Huic M, Mucolic V, Vrhovac B, et al. Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther 1994; 32 (12): 675-82
12. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9 (1): 51-9
13. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36 (9): 1331-6
14. Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Pharmacother 2003; 37 (1): 5-11
15. Donabedian A. The seven pillars of quality. Arch Pathol Lab Med 1990; 114 (11): 1115-8
16. Bates DW, Leape LL. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996; 275 (14): 1086-7
17. Halkin H, Katzir I, Kurman I, et al. Preventing drug interactions by online prescription screening in community pharmacies and medical practices. Clin Pharmacol Ther 2001; 69 (4): 260-5
18. Hazlet TK, Lee TA, Hansten PD, et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc 2001; 41 (2): 200-4
19. Heijboer-Vinks IC. Kwaliteitszorg in de medicatiebewaking. Den Haag: KNMP/WINAp, 1998
20. Tamblyn RM, Huang A, Perreault R, Jacques A, Roy D, Hanley J, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 3 A.D. 2003; 169 (6): 549-556
21. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth?: multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996; 154 (8): 1177-84
22. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996: 275 (14): 1086-7
23. Kraft KE, Dore FH. Computerized drug interactions programs: how reliable? [letter]. JAMA 1996; 275 (14): 1087
24. Currie JD, Chrischilles EA, Kuehl AK, et al. Effect of a training program on community pharmacists' detection of and intervention in drug-related problems. J Am Pharm Assoc 1997; NS37 (2): 182-91
25. Armstrong EP, Denemark CR. How pharmacists respond to on-line, real-time DUR alerts. J Am Pharm Assoc 1998; 38 (2): 149-54
26. van Mil JWF, Dudok van Heel MC, Boersma M, et al. Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Health Syst Pharm 2001; 58 (15): 1428-31